1. Home
  2. MCRB vs MDV Comparison

MCRB vs MDV Comparison

Compare MCRB & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$15.04

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$15.04

Market Cap

157.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCRB
MDV
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
157.4M
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
MCRB
MDV
Price
$15.04
$15.04
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$14.33
N/A
AVG Volume (30 Days)
43.7K
36.0K
Earning Date
03-12-2026
03-03-2026
Dividend Yield
N/A
7.83%
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$351,000.00
$47,479,000.00
Revenue This Year
N/A
$0.13
Revenue Next Year
N/A
$0.71
P/E Ratio
$24.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.53
$13.62
52 Week High
$29.98
$17.15

Technical Indicators

Market Signals
Indicator
MCRB
MDV
Relative Strength Index (RSI) 48.19 56.05
Support Level $14.41 $14.93
Resistance Level $16.12 $15.51
Average True Range (ATR) 0.83 0.34
MACD 0.03 0.04
Stochastic Oscillator 44.28 65.22

Price Performance

Historical Comparison
MCRB
MDV

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

Share on Social Networks: